Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
EDSAEdesa Biotech, Inc.
| Figure | EDSAEdesa Biotech, Inc.FY2021 · Sep |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | −100.0% |
| Net income | $7.19M |
| Net income, yoy | −16.5% |
| Net margin | — |
| Free cash flow | $6.64M |
| FCF margin | — |
| EPS, diluted | $1.10 |
Add another company.
Annual · FY2017–FY2021 · USD
From SEC EDGARSame fiscal periods, as filed